BrenA.Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis.Eur J Clin Microbiol Infect Dis1998; 17: 839–43.
2.
WangA.Y., YuA.W., LiP.K., LamP.K., LeungC.B., LaiK.N.Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center.Am J Kidney Dis2000; 36: 1183–92.
3.
BibashiE., PapagianniA., KelesidisA., AntoniadouR., PapadimitriouM.Peritonitis due to Aspergillus niger in a patient on continuous ambulatory peritoneal dialysis shortly after kidney graft rejection.Nephrol Dial Transplant1993; 8: 185–7.
4.
SridharR., Thornley–BrownD., KantK.S.Peritonitis due to Aspergillus niger: diagnostic importance of peritoneal eosinophilia.Perit Dial Int1990; 10: 100–1.
PetraitieneR., PetraitisV., GrollA.H., SeinT., PiscitelliS., CandelarioM.Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia.Antimicrob Agents Chemother2001; 45: 857–69.
8.
MaertensJ., TheunissenK., VerbekenE., LagrouK., VerhaegenJ., BoogaertsM.Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients.Br J Haematol2004; 126: 852–60.
ObayashiT., YoshidaM., MoriT., GotoH., YasuokaA., IwasakiH.Plasma (1→3)-β–d-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes.Lancet1995; 345: 17–20.